Tracked deals
9
9 tracked deals across 2021-2024.
London, England, United Kingdom
Sovereign Capital Partners is a specialist UK private equity house that partners with high-quality businesses and management teams to deliver transformational growth, with deep sector expertise in business and technology services, healthcare and pharma services, financial services and insurance, and education and training. Uses a Buy & Build strategy to create long-term value.
Tracked deals
9
9 tracked deals across 2021-2024.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
3 addon · 3 buyout · 3 growth capital
Last 4 years
Supporting Data
Skerritts, the Sovereign Capital Partners-backed UK wealth management group, has agreed to acquire Harrogate-based Ellis Bates Financial Advisers, with the transaction completing on 30 September 2024. The deal brings over 3,500 clients and more than £1 billion of AUM to the Skerritts Group (raising group AUM to £3.5 billion) and strengthens Skerritts' presence in the North of England as part of its buy-and-build strategy.
Clearwell Group, together with Sovereign's Capital and T-Street Capital, has partnered with Alpha EMC and HydroSpec to combine the two erosion-control and stormwater services businesses into the largest full-scope environmental services company in the southeastern United States. Fifth Third Bank provided financing support; the investors say the combination will expand service offerings across the construction lifecycle and accelerate geographic growth.
Sovereign's Capital, a lower middle-market private equity firm, has acquired Ascend Wireless Networks, a design-build telecommunications infrastructure and tower services contractor founded in 2013. Hyde Park Capital served as the exclusive sell-side advisor to Ascend's shareholders; the acquisition positions Ascend to expand its telecom infrastructure capabilities under Sovereign's ownership.
Murgitroyd, a portfolio company of Sovereign Capital Partners, has acquired UK-based Turnbull Lynch Intellectual Property Limited (TLIP) and Glasgow-based Creation IP. The add-on acquisitions expand Murgitroyd’s IP advisory capabilities, broaden its client base (from start-ups and SMEs to corporate clients in technology, electronics and biotechnology) and strengthen its UK footprint as part of a buy-and-build strategy.
Bioscript Group, a Sovereign Capital Partners-backed healthcare communications platform headquartered in Macclesfield, has acquired Meridian HealthComms. The deal is Bioscript's third acquisition since Sovereign backed the management team in March 2021 and expands the group's geographic footprint and service capabilities in medical communications, regulatory writing and market access.
Sovereign Capital Partners has completed a management buyout investment in Actica Consulting, a Guildford-based digital transformation and cyber security consultancy. The PE backing will support management-led growth both organically and via selective add-on acquisitions, while founders have reinvested and will remain on the board as non-executive directors.
Sovereign Capital Partners has completed a significant investment in AquaQ Analytics, a Belfast-based specialist data analytics and data science services firm that supports global financial institutions. The investment will partner with AquaQ's founders and management to expand the company's international presence and broaden its data analytics and software service offerings.
Sovereign Capital Partners has invested £55m to back Skerritts, an independent financial advisory and wealth management firm headquartered in Hove, England. The investment will partner the existing management team to accelerate organic growth and fund an acquisitive "buy & build" strategy to expand Skerritts' geographic footprint and capabilities.
Sovereign Capital Partners has completed a significant investment in Bioscript, a Macclesfield-based medical communications and regulatory writing agency, partnering with the management team to accelerate growth. The capital will support service development and geographic expansion as Bioscript looks to grow its UK and international presence.
Turn tracked acquisition activity into an outreach-ready buyer list.